Dividend Harvesting Portfolio Week 232: $23,200 Allocated, $2,467.76 In Projected DividendsSeeking Alpha • 08/14/25
Want Over $2,100 in Annual Dividends? Invest $12,000 Into Each of These 3 High-Yielding StocksThe Motley Fool • 08/13/25
Bristol Myers Squibb's Application for Breyanzi (lisocabtagene maraleucel) Accepted for Priority Review by U.S. Food and Drug Administration (FDA) in Fifth Cancer Type for Relapsed or Refractory Marginal Zone Lymphoma (MZL)Business Wire • 08/04/25
Bristol-Myers Squibb: No Respect For Blowout Earnings - Buy The Richer Dividend YieldsSeeking Alpha • 08/01/25
Bristol-Myers Q2 Earnings Review: Solid Quarter, But Incoming CMO Must Fix PipelineSeeking Alpha • 08/01/25
Pharmaceutical makers were largely unshaken by new demands from President Trump to lower drug prices, with experts saying the measures would either have modes impact or face legal challengesWSJ • 08/01/25
Bristol Myers Beats on Q2 Earnings and Sales, Raises '25 Sales ViewZacks Investment Research • 07/31/25
Bristol Myers Squibb (BMY) Q2 Earnings and Revenues Top EstimatesZacks Investment Research • 07/31/25
Bristol Myers posts better-than-expected second quarter results on strength of top sellersReuters • 07/31/25